L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed Revenue

In the year 2025, L&K Biomed had annual revenue of 38.92B KRW with 7.84% growth. L&K Biomed had revenue of 8.61B in the quarter ending December 31, 2025, a decrease of -14.11%.

• Revenue: 38.92B
• Revenue Growth: +7.84%
• P/S Ratio: 3.34
• Revenue / Employee: 385.35M
• Employees: n/a
• Market Cap: 129.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	38.92B	2.83B	7.84%
Dec 31, 2024	36.09B	6.19B	20.69%
Dec 31, 2023	29.90B	10.14B	51.28%
Dec 31, 2022	19.77B	4.39B	28.59%
Dec 31, 2021	15.37B	-3.98B	-20.58%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error